EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis

Xitong Li, Yvonne Liu, Johann-Georg Hocher, Chang Chu, Christoph Reichetzeder, Philipp Kalk, Angelika Szakallova, Xin Chen, Bernhard K Krämer, Martin Tepel, Berthold Hocher

Cardiorenal Medicine · 2024

DOI: 10.1159/000539765 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiorenal Medicine, 2024. Verfasst von Xitong Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannhe…. Hauptthemen laut MEDLINE: Renal Dialysis, Cell Adhesion Molecules, Kidney Failure, Chronic. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Periostin is a matricellular protein. Elevated serum concentrations of periostin have been reported in patients with various cardiovascular diseases, including heart failure. Patients with end-stage renal disease have a substantially increased risk for cardiovascular diseases. However, there is a lack of clinical studies to clarify the prognostic significance of systemic periostin on all-cause mortality in patients with end-stage renal disease on hemodialysis.

Methods

313 stable end-stage renal disease patients were recruited and followed for five years concerning all-cause mortality. At baseline, we collected blood samples and clinical data. Serum periostin concentrations were measured using a certified ELISA.

Results

The optimal cut-off value for serum periostin regarding all-cause mortality, calculated through ROC analysis, was 777.5 pmol/l. Kaplan-Meier survival analysis using this cut-off value demonstrated that higher periostin concentrations are linked to higher all-cause mortality (log-rank test: P = 0.002). Subgroup analysis revealed that serum periostin concentrations only affected all-cause mortality in male but not in female patients (P = 0.002 in male patients and P = 0.474 in female patients). Multivariate Cox regression analyses, adjusted for confounding factors, likewise showed that elevated serum periostin concentrations were positively associated with all-cause mortality in male (P = 0.028) but not in female patients on hemodialysis (P = 0.313).

Conclusion

Baseline serum periostin is an independent risk factor for all-cause mortality in male patients with chronic renal disease on hemodialysis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Renal DialysisCell Adhesion MoleculesKidney Failure, ChronicHumansFemaleMaleMiddle AgedAgedSex FactorsPrognosisCause of DeathBiomarkersRisk FactorsROC CurveKaplan-Meier EstimatePeriostin

Stichwörter der Autor:innen

All-cause mortalityHemodialysis patientsPeriostinSex dependency

Substanzen

Cell Adhesion MoleculesPOSTN protein, humanBiomarkersPeriostin

Autor:innen und Institutionen

  • Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany, lixitong0729@gmail.com.
  • Department of Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany, lixitong0729@gmail.com.
  • Fifth Department of Medicine (Nephrology/Endocrinology/Rheumatology/Pneumology), University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany.
  • Department of Medicine, Charité - Universitätsmedizin Berlin, Berlin, Germany.
  • Second Medical Faculty, Charles University of Prague, Prague, Czechia.
  • HMU - Health and Medical University, Potsdam, Germany.

Zitieren

APA

Li, X., Liu, Y., Hocher, J. G., Chu, C., Reichetzeder, C., Kalk, P., Szakallova, A., Chen, X., Krämer, B. K., Tepel, M., & Hocher, B. (2024). Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis. Cardiorenal Medicine. https://doi.org/10.1159/000539765

Vancouver

Li X, Liu Y, Hocher JG, Chu C, Reichetzeder C, Kalk P, et al. Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis. Cardiorenal Medicine. 2024. doi:10.1159/000539765

BibTeX
@article{Li2024,
  author = {Li, Xitong and Liu, Yvonne and Hocher, Johann-Georg and Chu, Chang and Reichetzeder, Christoph and Kalk, Philipp and Szakallova, Angelika and Chen, Xin and Krämer, Bernhard K and Tepel, Martin and Hocher, Berthold},
  title = {Periostin predicts all-cause mortality in male but not female end-stage renal disease patients on hemodialysis},
  journal = {Cardiorenal Medicine},
  year = {2024},
  doi = {10.1159/000539765}
}
Kostenlos starten →